Bio-Techne (TECH) Dividend Coverage Ratio (QoQ) (2009 - 2026)
Analysis
Bio-Techne (TECH) Dividend Coverage Ratio (QoQ) (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.58 Bn | 130.73 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.33 Bn | 77.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.43 Bn | 58.24 Bn | 1.37 Bn |
| 4 | Moderna | 57.84 Bn | 52.70 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.01 Bn | 44.01 Bn | - |
| 6 | BeOne Medicines | 39.93 Bn | 34.83 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.47 Bn | 32.16 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.39 Bn | 27.56 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Bio-Techne | 11.29 Bn | 11.03 Bn | 211.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.29% |
| Mar 31, 2026 | 33.79% |
| Dec 31, 2025 | -0.67% |
| Sep 30, 2025 | 155.22% |
| Jun 30, 2025 | -409.47% |
| Mar 31, 2025 | -34.46% |
| Dec 31, 2024 | 3.45% |
| Sep 30, 2024 | 7,731.02% |
| Jun 30, 2024 | -99.13% |
| Mar 31, 2024 | 78.34% |
| Dec 31, 2023 | -45.73% |
| Sep 30, 2023 | 11.12% |
| Jun 30, 2023 | -35.02% |
| Mar 31, 2023 | 40.19% |
| Dec 31, 2022 | -44.35% |
| Sep 30, 2022 | 44.86% |
| Jun 30, 2022 | 3.26% |
| Mar 31, 2022 | -16.54% |
| Dec 31, 2021 | 3.77% |
| Sep 30, 2021 | 614.12% |